Wednesday, July 8, 2026

pharma · Asthma · Pharmacokinetics · AMPH

Amphastar France Pharmaceuticals

Amphastar France Pharmaceuticals clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

USINE SAINT CHARLES, ERAGNY SUR EPTE, 60590, FR, Rancho Cucamonga HQ
1996 Founded
46 Employees
Public company Type
AMPH · NYSE Ticker
Company details
Status
Public
HQ
USINE SAINT CHARLES, ERAGNY SUR EPTE, 60590, FR, Rancho Cucamonga
Founded
1996
Employees
46
Programs
18
Drugs
15
Patents
15
Intelligence · Clinical Programs

Amphastar France Pharmaceuticals projects

1 ClinicalTrials.gov programs sponsored by Amphastar France Pharmaceuticals.

Amphastar France Pharmaceuticals has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Epinephrine (0.125 mg/inhalation)

    Amphastar France Pharmaceuticals

    Pharmacokinetics

    approved other completed

    1 trial

Frequently asked questions

How many clinical projects does Amphastar France Pharmaceuticals have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.